KR102656918B1 - Organic compounds and organic electro luminescence device comprising the same - Google Patents

Organic compounds and organic electro luminescence device comprising the same Download PDF

Info

Publication number
KR102656918B1
KR102656918B1 KR1020150171591A KR20150171591A KR102656918B1 KR 102656918 B1 KR102656918 B1 KR 102656918B1 KR 1020150171591 A KR1020150171591 A KR 1020150171591A KR 20150171591 A KR20150171591 A KR 20150171591A KR 102656918 B1 KR102656918 B1 KR 102656918B1
Authority
KR
South Korea
Prior art keywords
group
aryl
mmol
alkyl
layer
Prior art date
Application number
KR1020150171591A
Other languages
Korean (ko)
Other versions
KR20170065317A (en
Inventor
손호준
김충한
Original Assignee
솔루스첨단소재 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 솔루스첨단소재 주식회사 filed Critical 솔루스첨단소재 주식회사
Priority to KR1020150171591A priority Critical patent/KR102656918B1/en
Priority to PCT/KR2016/013827 priority patent/WO2017095100A1/en
Publication of KR20170065317A publication Critical patent/KR20170065317A/en
Application granted granted Critical
Publication of KR102656918B1 publication Critical patent/KR102656918B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D251/00Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K11/00Luminescent, e.g. electroluminescent, chemiluminescent materials
    • C09K11/06Luminescent, e.g. electroluminescent, chemiluminescent materials containing organic luminescent materials
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/654Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K85/00Organic materials used in the body or electrodes of devices covered by this subclass
    • H10K85/60Organic compounds having low molecular weight
    • H10K85/649Aromatic compounds comprising a hetero atom
    • H10K85/657Polycyclic condensed heteroaromatic hydrocarbons
    • H10K85/6572Polycyclic condensed heteroaromatic hydrocarbons comprising only nitrogen in the heteroaromatic polycondensed ring system, e.g. phenanthroline or carbazole
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1003Carbocyclic compounds
    • C09K2211/1007Non-condensed systems
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1029Heterocyclic compounds characterised by ligands containing one nitrogen atom as the heteroatom
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2211/00Chemical nature of organic luminescent or tenebrescent compounds
    • C09K2211/10Non-macromolecular compounds
    • C09K2211/1018Heterocyclic compounds
    • C09K2211/1025Heterocyclic compounds characterised by ligands
    • C09K2211/1059Heterocyclic compounds characterised by ligands containing three nitrogen atoms as heteroatoms
    • HELECTRICITY
    • H10SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
    • H10KORGANIC ELECTRIC SOLID-STATE DEVICES
    • H10K50/00Organic light-emitting devices
    • H10K50/10OLEDs or polymer light-emitting diodes [PLED]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Optics & Photonics (AREA)

Abstract

본 발명은 신규 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것으로서, 본 발명에 따른 화합물은 유기 전계 발광 소자의 유기물층, 바람직하게는 전자 수송층에 사용됨에 따라 유기 전계 발광 소자의 발광 효율, 구동 전압, 수명 등을 향상시킬 수 있다.The present invention relates to a novel compound and an organic electroluminescent device containing the same. The compound according to the present invention is used in an organic material layer, preferably an electron transport layer, of an organic electroluminescent device, thereby increasing the luminous efficiency, driving voltage, and Lifespan can be improved.

Description

유기 화합물 및 이를 포함하는 유기 전계 발광 소자{ORGANIC COMPOUNDS AND ORGANIC ELECTRO LUMINESCENCE DEVICE COMPRISING THE SAME}Organic compounds and organic electroluminescent devices containing the same {ORGANIC COMPOUNDS AND ORGANIC ELECTRO LUMINESCENCE DEVICE COMPRISING THE SAME}

본 발명은 유기 전계 발광 소자용 재료로서 사용될 수 있는 신규 유기 화합물 및 이를 포함하는 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic compound that can be used as a material for an organic electroluminescent device and an organic electroluminescent device containing the same.

1950년대 베르나소스(Bernanose)의 유기 박막 발광 관측을 시점으로 하여, 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광(electroluminescent, EL) 소자에 대한 연구가 이어져 오다가, 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 전계 발광 소자가 제시되었다. 이후, 고효율, 고수명의 유기 전계 발광 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다.Beginning with the observation of organic thin film luminescence by Bernanose in the 1950s, research on organic electroluminescent (EL) devices continued, leading to blue electroluminescence using anthracene single crystals in 1965, and Tang in 1987. ) presented an organic electroluminescent device with a layered structure divided into a functional layer of a hole layer and a light-emitting layer. Since then, in order to create high-efficiency, long-life organic electroluminescent devices, there has been development in the form of introducing each characteristic organic material layer within the device, leading to the development of specialized materials used for this.

유기 전계 발광 소자는 두 전극 사이에 전압을 걸어주면 양극에서는 정공이 유기물층으로 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때, 유기물층으로 사용되는 물질은 그 기능에 따라, 발광 물질, 정공주입 물질, 정공수송 물질, 전자수송 물질, 전자주입 물질 등으로 분류될 수 있다.In an organic electroluminescent device, when a voltage is applied between two electrodes, holes are injected into the organic material layer from the anode, and electrons are injected into the organic material layer from the cathode. When the injected hole and electron meet, an exciton is formed, and when this exciton falls to the ground state, light is emitted. At this time, the material used as the organic material layer can be classified into light-emitting material, hole injection material, hole transport material, electron transport material, electron injection material, etc., depending on its function.

발광 물질은 발광색에 따라 청색, 녹색, 적색 발광 물질과, 보다 나은 천연색을 구현하기 위한 노란색 및 주황색 발광 물질로 구분될 수 있다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 물질로서 호스트/도펀트 계를 사용할 수 있다.Light-emitting materials can be divided into blue, green, and red light-emitting materials according to their emission color, and yellow and orange light-emitting materials to achieve better natural colors. Additionally, in order to increase color purity and increase luminous efficiency through energy transfer, a host/dopant system can be used as a luminescent material.

도펀트 물질은 유기 물질을 사용하는 형광 도펀트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도펀트로 나눌 수 있다. 이때, 인광 재료의 개발은 이론적으로 형광에 비해 4배까지 발광 효율을 향상시킬 수 있기 때문에, 인광 도펀트 뿐만 아니라 인광 호스트 재료들에 대한 연구도 많이 진행되고 있다.Dopant materials can be divided into fluorescent dopants using organic materials and phosphorescent dopants using metal complex compounds containing heavy atoms such as Ir and Pt. At this time, because the development of phosphorescent materials can theoretically improve luminous efficiency by up to four times compared to fluorescence, much research is being conducted on phosphorescent host materials as well as phosphorescent dopants.

현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층 재료로는 NPB, BCP, Alq3 등이 널리 알려져 있으며, 발광층 재료로는 안트라센 유도체들이 보고되고 있다. 특히, 발광층 재료 중 효율 향상 측면에서 장점을 가지고 있는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색(blue), 녹색(green), 적색(red)의 인광 도판트 재료로 사용되고 있으며, 4,4-디카바졸리비페닐(4,4-dicarbazolybiphenyl, CBP)은 인광 호스트 재료로 사용되고 있다.So far, hole injection layer and hole transport layer. NPB, BCP, Alq 3 , etc. are widely known as hole blocking layer and electron transport layer materials, and anthracene derivatives are reported as light emitting layer materials. In particular, metal complex compounds containing Ir, such as Firpic, Ir(ppy) 3 , and (acac)Ir(btp) 2 , which have advantages in terms of efficiency improvement among light emitting layer materials, produce blue, green, and red colors. (red) is used as a phosphorescent dopant material, and 4,4-dicarbazolybiphenyl (CBP) is used as a phosphorescent host material.

Figure 112017002963439-pat00066
Figure 112017002963439-pat00066

삭제delete

그러나 종래의 유기물층 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮아 열적 안정성이 매우 좋지 않기 때문에, 유기 전계 발광 소자의 수명 측면에서 만족할 만한 수준이 되지 못하고 있다. 따라서, 성능이 뛰어난 유기물층 재료의 개발이 요구되고 있다.However, although conventional organic layer materials have advantages in terms of luminescence characteristics, their glass transition temperature is low and thermal stability is very poor, so they are not at a satisfactory level in terms of the lifespan of organic electroluminescent devices. Therefore, the development of organic layer materials with excellent performance is required.

본 발명은 상기한 문제점을 해결하기 위해, 유기 전계 발광 소자의 효율, 수명 및 안정성 등을 향상시킬 수 있는 신규 화합물 및 상기 화합물을 이용한 유기 전계 발광 소자를 제공하는 것을 목적으로 한다.In order to solve the above problems, the purpose of the present invention is to provide a new compound that can improve the efficiency, lifespan, and stability of an organic electroluminescent device and an organic electroluminescent device using the compound.

상기한 목적을 달성하기 위해, 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다:In order to achieve the above object, the present invention provides a compound represented by the following formula (1):

[화학식 1][Formula 1]

상기 화학식 1에서, In Formula 1,

X1 및 X2는 각각 독립적으로 N 또는 C(R5)이나, 상기 X1 및 X2 중 적어도 하나는 N이고;X 1 and X 2 are each independently N or C(R 5 ), but at least one of X 1 and X 2 is N;

m 및 n은 각각 독립적으로 0 내지 5의 정수이며; m and n are each independently integers from 0 to 5;

R1 및 R2는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 상기 R1 및 R2 각각이 복수 개인 경우 이들은 서로 동일하거나 상이하며; R 1 and R 2 are each independently selected from deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 Cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 6 to C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 1 to C 40 alkyloxy group, C 6 to C 60 Aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 is selected from the group consisting of an arylphosphine group, a C 6 ~ C 60 mono or diarylphosphinyl group, and a C 6 ~ C 60 arylamine group, and when each of R 1 and R 2 is plural, they are the same or different from each other and;

L1 내지 L3는 각각 독립적으로 단일결합, C6~C30의 아릴렌기 및 핵원자수 5 내지 30개의 헤테로아릴렌기로 이루어진 군에서 선택되며;L 1 to L 3 are each independently selected from the group consisting of a single bond, a C 6 to C 30 arylene group, and a heteroarylene group having 5 to 30 nuclear atoms;

R3 내지 R5는 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되며;R 3 to R 5 are each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 6 to C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 1 to C 40 alkyloxy group, C 6 to C 60 aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ selected from the group consisting of a C 60 arylphosphine group, a C 6 to C 60 mono or diarylphosphinyl group, and a C 6 to C 60 arylamine group;

상기 L1 내지 L3의 아릴렌기 및 헤테로아릴렌기와, R1 내지 R5의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며;The arylene group and heteroarylene group of L 1 to L 3 and the alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, cycloalkyl group, heterocycloalkyl group of R 1 to R 5 , arylamine group, alkylsilyl group, alkylboron group, arylboron group, arylphosphine group, mono or diarylphosphinyl group, and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 Alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group , C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 arylamine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group. , C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 mono or diarylphosphinyl group and C 6 ~ C 60 is substituted or unsubstituted with one or more substituents selected from the group consisting of arylsilyl groups, and when substituted with a plurality of substituents, these may be the same or different from each other;

상기 R3 및 R4 중 적어도 하나는 하기 화학식 2 또는 3으로 표시되는 치환기에서 선택되고; At least one of R 3 and R 4 is selected from the substituents represented by Formula 2 or 3 below;

[화학식 2][Formula 2]

[화학식 3][Formula 3]

상기 화학식 2 및 3에서,In Formulas 2 and 3,

*은 결합이 이루어지는 부분을 의미하고;* refers to the part where the combination takes place;

X1 내지 X10은 각각 독립적으로 N 또는 C(R6)이나, 상기 X1 내지 X10 중 적어도 하나는 N이며;X 1 to X 10 are each independently N or C(R 6 ), but at least one of X 1 to X 10 is N;

R6은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 상기 R6이 복수 개인 경우 이들은 서로 동일하거나 상이하며;R 6 is hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, Heterocycloalkyl group with 3 to 40 nuclear atoms, aryl group with C 6 to C 60 , heteroaryl group with 5 to 60 nuclear atoms, alkyloxy group with C 1 to C 40 , aryloxy group with C 6 to C 60 , C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 arylphosphine group , is selected from the group consisting of a C 6 ~ C 60 mono or diarylphosphinyl group and a C 6 ~ C 60 arylamine group, and when there is a plurality of R 6 , they are the same or different from each other;

상기 R6의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있다.The alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, cycloalkyl group , heterocycloalkyl group, arylamine group, alkylsilyl group, alkyl boron group, aryl boron group, Arylphosphine group, mono or diarylphosphinyl group, and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 Alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 Arylamine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 Unsubstituted or substituted with one or more substituents selected from the group consisting of arylboron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 mono or diarylphosphinyl group, and C 6 ~ C 60 arylsilyl group. And when substituted with a plurality of substituents, these may be the same or different from each other.

본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하며, 상기 1층 이상의 유기물층 중에서 적어도 하나는 상기 화학식 1의 화합물을 포함하는 유기 전계 발광 소자를 제공한다.The present invention provides an organic electroluminescent device comprising an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, and at least one of the one or more organic material layers includes the compound of Formula 1. .

본 발명에서의 "알킬"은 탄소수 1 내지 40개의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등이 있는데, 이에 한정되지 않는다.In the present invention, “alkyl” is a monovalent substituent derived from a straight-chain or branched-chain saturated hydrocarbon having 1 to 40 carbon atoms, examples of which include methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, and hexyl. etc., but is not limited to this.

본 발명에서의 "알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진, 탄소수 2 내지 40개의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등이 있는데, 이에 한정되지 않는다.In the present invention, “alkenyl” is a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon double bond, examples of which include vinyl, Examples include allyl, isopropenyl, 2-butenyl, etc., but are not limited thereto.

본 발명에서의 "알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진, 탄소수 2 내지 40개의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기이며, 이의 예로는 에티닐(ethynyl), 2-프로파닐(2-propynyl) 등이 있는데, 이에 한정되지 않는다.In the present invention, “alkynyl” is a monovalent substituent derived from a straight or branched chain unsaturated hydrocarbon having 2 to 40 carbon atoms and having at least one carbon-carbon triple bond, examples of which include ethynyl. , 2-propynyl, etc., but is not limited thereto.

본 발명에서의 "아릴"은 단독 고리 또는 2 이상의 고리가 조합된, 탄소수 6 내지 60개의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있다. 이러한 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등이 있는데, 이에 한정되지 않는다.In the present invention, “aryl” refers to a monovalent substituent derived from an aromatic hydrocarbon having 6 to 60 carbon atoms, either a single ring or a combination of two or more rings. In addition, a form in which two or more rings are simply attached to each other (pendant) or condensed may also be included. Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, and anthryl.

본 발명에서의 "헤테로아릴"은 핵원자수 5 내지 60개의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이때, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있고, 나아가 아릴기와의 축합된 형태도 포함하는 것으로 해석한다. 이러한 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리; 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리; 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등이 있는데, 이에 한정되지 않는다.In the present invention, “heteroaryl” refers to a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 60 nuclear atoms. At this time, at least one carbon in the ring, preferably 1 to 3 carbons, is replaced with a heteroatom such as N, O, S or Se. In addition, a form in which two or more rings are simply pendant or condensed with each other may be included, and it is further interpreted to include a condensed form with an aryl group. Examples of such heteroaryls include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, and triazinyl; Polycyclics such as phenoxathienyl, indolizinyl, indolyl, purinyl, quinolyl, benzothiazole, carbazolyl ring; Examples include 2-furanyl, N-imidazolyl, 2-isoxazolyl, 2-pyridinyl, 2-pyrimidinyl, etc., but are not limited thereto.

본 발명에서의 "아릴옥시"는 RO-로 표시되는 1가의 치환기로, 상기 R은 탄소수 5 내지 60개의 아릴을 의미한다. 이러한 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등이 있는데, 이에 한정되지 않는다.In the present invention, “aryloxy” is a monovalent substituent represented by RO-, where R means aryl having 5 to 60 carbon atoms. Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, and diphenyloxy.

본 발명에서의 "알킬옥시"는 R'O-로 표시되는 1가의 치환기로, 상기 R'는 1 내지 40개의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함하는 것으로 해석한다. 이러한 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등이 있는데, 이에 한정되지 않는다.In the present invention, "alkyloxy" is a monovalent substituent represented by R'O-, where R' means 1 to 40 alkyl, and has a linear, branched or cyclic structure. It is interpreted as including. Examples of such alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, and pentoxy.

본 발명에서의 "아릴아민"은 탄소수 6 내지 60개의 아릴로 치환된 아민을 의미한다.In the present invention, “arylamine” refers to an amine substituted with aryl having 6 to 60 carbon atoms.

본 발명에서의 "시클로알킬"은 탄소수 3 내지 40개의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 놀보닐(norbornyl), 아다만틴(adamantine) 등이 있는데, 이에 한정되지 않는다.“Cycloalkyl” in the present invention refers to a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms. Examples of such cycloalkyl include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, and adamantine.

본 발명에서의 "헤테로시클로알킬"은 핵원자수 3 내지 40개의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로 원자로 치환된다. 이러한 헤테로시클로알킬의 예로는 모르폴린, 피페라진 등이 있는데, 이에 한정되지 않는다.In the present invention, “heterocycloalkyl” refers to a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, and at least one carbon, preferably 1 to 3 carbons in the ring, is N, O, It is substituted with a hetero atom such as S or Se. Examples of such heterocycloalkyl include, but are not limited to, morpholine and piperazine.

본 발명에서의 "알킬실릴"은 탄소수 1 내지 40개의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 60개의 아릴로 치환된 실릴을 의미한다.In the present invention, “alkylsilyl” refers to silyl substituted with alkyl having 1 to 40 carbon atoms, and “arylsilyl” refers to silyl substituted with aryl having 5 to 60 carbon atoms.

본 발명에서의 "축합 고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.“Condensed ring” in the present invention means a fused aliphatic ring, a fused aromatic ring, a fused heteroaliphatic ring, a fused heteroaromatic ring, or a combination thereof.

본 발명에 따른 화학식 1로 표시되는 화합물은 열적 안정성, 정공 수송, 정공 주입 성능, 전자 수송 및 전자 주입 성능이 우수하고, 전자 이동도가 빠르기 때문에 유기 전계 발광 소자의 유기물층 재료, 바람직하게는 발광층 재료, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층으로 이용될 수 있다. The compound represented by Formula 1 according to the present invention has excellent thermal stability, hole transport, hole injection performance, electron transport and electron injection performance, and has fast electron mobility, so it can be used as an organic layer material, preferably a light-emitting layer material, of an organic electroluminescent device. , can be used as a hole injection layer, hole transport layer, electron injection layer, and electron transport layer.

본 발명의 화학식 1로 표시되는 신규 화합물은 발광층 재료, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층으로 사용할 경우, 종래 물질에 비해 우수한 발광 성능, 낮은 구동전압, 높은 효율 및 장수명을 갖는 유기 전계 발광 소자를 제조할 수 있고, 나아가 성능 및 수명이 크게 향상된 풀 칼라 디스플레이 패널도 제조할 수 있다.The novel compound represented by Formula 1 of the present invention is an organic compound that has superior luminescence performance, low driving voltage, high efficiency, and long lifespan compared to conventional materials when used as a light-emitting layer material, hole injection layer, hole transport layer, electron injection layer, and electron transport layer. Electroluminescent devices can be manufactured, and full-color display panels with greatly improved performance and lifespan can also be manufactured.

이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.

1. 신규 유기 화합물1. Novel organic compounds

본 발명에 따른 신규 유기 화합물은 피리미딘 또는 트리아진을 축으로 Y자 형태의 기본 골격에 아릴기 및 헤테로아릴기가 결합된 구조를 갖는다. 본 발명에서는 상기한 기본 골격에 헤테로 원자의 위치와 수를 변화시켜, 예컨대, 페난트리딘, 벤조나프티리딘, 피리도퀴녹살린 등과 같이 전자 흡수성이 큰 전자 끌개기(EWG)가 결합되어 분자 전체가 전자 이동도를 높일 수 있다. 구체적으로, 본 발명의 신규 화합물은 하기 화학식 1로 표시되는 화합물인 것을 특징으로 한다:The new organic compound according to the present invention has a structure in which an aryl group and a heteroaryl group are bonded to a Y-shaped basic skeleton centered on pyrimidine or triazine. In the present invention, by changing the position and number of hetero atoms in the basic skeleton described above, an electron attractor (EWG) with high electron absorption, such as phenanthridine, benzonaphthyridine, pyridoquinoxaline, etc., is bonded to the entire molecule. Electron mobility can be increased. Specifically, the novel compound of the present invention is characterized as a compound represented by the following formula (1):

[화학식 1][Formula 1]

상기 화학식 1에서, In Formula 1,

X1 및 X2는 각각 독립적으로 N 또는 C(R5)이나, 상기 X1 및 X2 중 적어도 하나는 N이고;X 1 and X 2 are each independently N or C(R 5 ), but at least one of X 1 and X 2 is N;

m 및 n은 각각 독립적으로 0 내지 5의 정수이며; m and n are each independently integers from 0 to 5;

R1 및 R2는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 상기 R1 및 R2 각각이 복수 개인 경우 이들은 서로 동일하거나 상이하며; R 1 and R 2 are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 Cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 6 to C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 1 to C 40 alkyloxy group, C 6 to C 60 Aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 is selected from the group consisting of an arylphosphine group, a C 6 ~ C 60 mono or diarylphosphinyl group, and a C 6 ~ C 60 arylamine group, and when each of R 1 and R 2 is plural, they are the same or different from each other and;

L1 내지 L3는 각각 독립적으로 단일결합, C6~C30의 아릴렌기 및 핵원자수 5 내지 30개의 헤테로아릴렌기로 이루어진 군에서 선택되며;L 1 to L 3 are each independently selected from the group consisting of a single bond, a C 6 to C 30 arylene group, and a heteroarylene group having 5 to 30 nuclear atoms;

R3 내지 R5는 각각 독립적으로 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되며;R 3 to R 5 are each independently hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 6 to C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 1 to C 40 alkyloxy group, C 6 to C 60 aryloxy group, C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ selected from the group consisting of a C 60 arylphosphine group, a C 6 to C 60 mono or diarylphosphinyl group, and a C 6 to C 60 arylamine group;

상기 L1 내지 L3의 아릴렌기 및 헤테로아릴렌기와, R1 내지 R5의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있다.The arylene group and heteroarylene group of L 1 to L 3 and the alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, cycloalkyl group, heterocycloalkyl group of R 1 to R 5 , arylamine group, alkylsilyl group, alkylboron group, arylboron group, arylphosphine group, mono or diarylphosphinyl group, and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 Alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group , C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 arylamine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group. , C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 mono or diarylphosphinyl group and C 6 ~ C 60 is substituted or unsubstituted with one or more substituents selected from the group consisting of arylsilyl groups, and when substituted with a plurality of substituents, these may be the same or different from each other.

본 발명의 바람직한 한 구현 예에 따르면, 상기 R3 및 R4 중 적어도 하나는 하기 화학식 2 또는 화학식 3으로 표시되는 치환기인 것이 발광 효율 측면에서 바람직하나, 이에 제한되는 것은 아니다:According to a preferred embodiment of the present invention, it is preferable in terms of luminous efficiency that at least one of R 3 and R 4 is a substituent represented by the following Formula 2 or Formula 3, but is not limited thereto:

[화학식 2][Formula 2]

[화학식 3][Formula 3]

상기 화학식 2 및 화학식 3에서,In Formula 2 and Formula 3,

*은 결합이 이루어지는 부분을 의미하고;* refers to the part where the combination takes place;

X1 내지 X10은 각각 독립적으로 N 또는 C(R6)이나, 상기 X1 내지 X10 중 적어도 하나는 N이며;X 1 to X 10 are each independently N or C(R 6 ), but at least one of X 1 to X 10 is N;

R6은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되거나, 또는 인접하는 기(예컨대, L2 및 인접하는 다른 R6 등)와 결합하여 축합 고리를 형성할 수 있고, 상기 R6이 복수 개인 경우 이들은 서로 동일하거나 상이하며;R 6 is hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 60 aryl group, Heteroaryl group with 5 to 60 nuclear atoms, aryloxy group with C 6 to C 60 , alkyloxy group with C 1 to C 40 , cycloalkyl group with C 3 to C 40 , heterocycloalkyl group with 3 to 40 nuclear atoms. , C 6 ~ C 60 arylamine group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 arylphosphine group , C 6 ~ C 60 mono or diarylphosphinyl group and C 6 ~ C 60 arylsilyl group, or in combination with an adjacent group (for example, L 2 and other adjacent R 6 , etc.) may form a condensed ring, and when R 6 is plural, they are the same or different from each other;

상기 R6의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있다.The alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, cycloalkyl group , heterocycloalkyl group, arylamine group, alkylsilyl group, alkyl boron group, aryl boron group, Arylphosphine group, mono or diarylphosphinyl group, and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 Alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 Arylamine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 Unsubstituted or substituted with one or more substituents selected from the group consisting of arylboron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 mono or diarylphosphinyl group, and C 6 ~ C 60 arylsilyl group. And when substituted with a plurality of substituents, these may be the same or different from each other.

본 발명의 화합물은 페난트렌 치환기의 기본 골격에 질소의 개수 및 위치를 변화시켜 빠른 전자 이동도를 가질 수 있다. 이로 인해 전자 수송층의 성능을 높여 유기 전계 발광 소자의 효율을 높일 수 있다. 또한 발광층으로 엑시톤의 수 증가에 기여하여 소자의 발광 효율이 개선될 수 있고, 소자의 내구성 및 안정성이 향상되어 소자의 수명이 효율적으로 증가될 수 있다.The compound of the present invention can have fast electron mobility by changing the number and position of nitrogen in the basic skeleton of the phenanthrene substituent. As a result, the efficiency of the organic electroluminescent device can be increased by increasing the performance of the electron transport layer. In addition, the light-emitting layer contributes to an increase in the number of excitons, which can improve the luminous efficiency of the device, and improve the durability and stability of the device, effectively increasing the lifespan of the device.

본 발명의 바람직한 한 구현 예에 따르면, 상기 화학식 2로 표시되는 치환기는 하기 화학식 A-1 내지 A-11 중 어느 하나로 표시되는 치환기일 수 있다:According to a preferred embodiment of the present invention, the substituent represented by Formula 2 may be a substituent represented by any one of the following Formulas A-1 to A-11:

상기 화학식 A-1 내지 A-11에서, In the above formulas A-1 to A-11,

p는 0 내지 4의 정수이며;p is an integer from 0 to 4;

q는 0 내지 3의 정수이며;q is an integer from 0 to 3;

r 및 s는 각각 독립적으로 0 내지 2의 정수이며;r and s are each independently integers from 0 to 2;

R7 및 R8은 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되거나, 또는 인접하는 기(예컨대, L2, 인접하는 다른 R7 또는 R8 등)와 결합하여 축합 고리를 형성할 수 있고, 상기 R7 및 R8 각각이 복수 개인 경우 이들은 서로 동일하거나 상이하며;R 7 and R 8 are each independently selected from deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 60 Aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 to C 60 aryloxy group, C 1 to C 40 alkyloxy group, C 3 to C 40 cycloalkyl group, 3 to 40 nuclear atoms Heterocycloalkyl group, C 6 ~ C 60 arylamine group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 is selected from the group consisting of an arylphosphine group, a C 6 ~ C 60 mono or diarylphosphinyl group, and a C 6 ~ C 60 arylsilyl group, or an adjacent group (for example, L 2 , another adjacent R 7 or R 8 , etc.) may be combined to form a condensed ring, and when each of R 7 and R 8 is plural, they are the same or different from each other;

상기 R7 및 R8의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며,The alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, cycloalkyl group, heterocycloalkyl group, arylamine group, alkylsilyl group, alkylboron group, aryl group of R 7 and R 8 Boron group, arylphosphine group, mono or diarylphosphinyl group, and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ Arylamine group of C 60 , cycloalkyl group of C 3 ~ C 40 , heterocycloalkyl group of 3 to 40 nuclear atoms, alkylsilyl group of C 1 ~ C 40 , alkyl boron group of C 1 ~ C 40 , C 6 ~ Substituted with one or more substituents selected from the group consisting of C 60 arylboron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 mono or diarylphosphinyl group, and C 6 ~ C 60 arylsilyl group. When unsubstituted or substituted with a plurality of substituents, they may be the same or different from each other,

* 및 R6은 상기 화학식 2에서 정의된 바와 같다.* and R 6 are as defined in Formula 2 above.

본 발명의 바람직한 한 구현 예에 따르면, 상기 화학식 3으로 표시되는 치환기는 하기 화학식 B-1 내지 B-6 중 어느 하나로 표시되는 치환기일 수 있다:According to a preferred embodiment of the present invention, the substituent represented by Formula 3 may be a substituent represented by any one of the following Formulas B-1 to B-6:

상기 화학식 B-1 내지 B-6에서, In the above formulas B-1 to B-6,

*은 결합이 이루어지는 부분을 의미하고;* refers to the part where the combination takes place;

p 및 l은 각각 독립적으로 0 내지 4의 정수이며;p and l are each independently an integer from 0 to 4;

q 및 t는 각각 독립적으로 0 내지 3의 정수이며;q and t are each independently integers from 0 to 3;

s는 0 내지 2의 정수이며;s is an integer from 0 to 2;

R7 및 R8은 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되거나, 또는 인접하는 기(예컨대, L2, 인접하는 다른 R7 또는 R8 등)와 결합하여 축합 고리를 형성할 수 있고, 상기 R7 및 R3 각각이 복수 개인 경우 이들은 서로 동일하거나 상이하며;R 7 and R 8 are each independently selected from deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 60 Aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 to C 60 aryloxy group, C 1 to C 40 alkyloxy group, C 3 to C 40 cycloalkyl group, 3 to 40 nuclear atoms Heterocycloalkyl group, C 6 ~ C 60 arylamine group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 is selected from the group consisting of an arylphosphine group, a C 6 ~ C 60 mono or diarylphosphinyl group, and a C 6 ~ C 60 arylsilyl group, or an adjacent group (for example, L 2 , another adjacent R 7 or R 8 , etc.) may be combined to form a condensed ring, and when each of R 7 and R 3 is plural, they are the same or different from each other;

상기 R7 및 R8의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있다.The alkyl group, alkenyl group, alkynyl group, aryl group, heteroaryl group, aryloxy group, alkyloxy group, cycloalkyl group, heterocycloalkyl group, arylamine group, alkylsilyl group, alkylboron group, aryl group of R 7 and R 8 Boron group, arylphosphine group, mono or diarylphosphinyl group, and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ Arylamine group of C 60 , cycloalkyl group of C 3 ~ C 40 , heterocycloalkyl group of 3 to 40 nuclear atoms, alkylsilyl group of C 1 ~ C 40 , alkyl boron group of C 1 ~ C 40 , C 6 ~ Substituted with one or more substituents selected from the group consisting of C 60 arylboron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 mono or diarylphosphinyl group, and C 6 ~ C 60 arylsilyl group. When substituted or unsubstituted and substituted with a plurality of substituents, they may be the same or different from each other.

본 발명의 바람직한 한 구현 예에 따르면, 상기 L1 내지 L3는 각각 독립적으로 단일결합 또는 C6~C18의 아릴렌기일 수 있다. According to a preferred embodiment of the present invention, L 1 to L 3 may each independently be a single bond or a C 6 to C 18 arylene group.

본 발명의 바람직한 한 구현 예에 따르면, 상기 L1 내지 L3는 각각 독립적으로 단일결합, 페닐렌기, 비페닐렌기, 나프탈레닐기 및 안트라세닐기로 이루어진 군에서 선택될 수 있다.According to a preferred embodiment of the present invention, L 1 to L 3 may each independently be selected from the group consisting of a single bond, a phenylene group, a biphenylene group, a naphthalenyl group, and an anthracenyl group.

본 발명의 바람직한 한 구현 예에 따르면, 상기 R3는 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기 또는 핵원자수 5 내지 60개의 헤테로아릴기일 수 있다. According to a preferred embodiment of the present invention, R 3 is a C 1 ~ C 40 alkyl group, a C 2 ~ C 40 alkenyl group, a C 2 ~ C 40 alkynyl group, a C 6 ~ C 60 aryl group, or a nucleus. It may be a heteroaryl group having 5 to 60 atoms.

본 발명의 바람직한 한 구현 예에 따르면, 상기 R3는 메틸, 프로필, 부틸, 페닐기, 비페닐기, 나프탈레닐기, 안트라세닐기, 페난트레닐기, 피레닐기, 트리페닐레닐기, 플루오레닐기, 스파이로비플루오레닐기 및 벤조플루오레닐기로 이루어진 군에서 선택될 수 있다. According to a preferred embodiment of the present invention, R 3 is methyl, propyl, butyl, phenyl, biphenyl, naphthalenyl, anthracenyl, phenanthrenyl, pyrenyl, triphenylenyl, fluorenyl, spy. It may be selected from the group consisting of lobifluorenyl group and benzofluorenyl group.

본 발명의 화학식 1로 표시되는 화합물은 하기 화합물로 나타낼 수 있으나 이에 한정되는 것은 아니다:

Figure 112017002963439-pat00067

Figure 112017002963439-pat00068

Figure 112017002963439-pat00069

Figure 112017002963439-pat00070

Figure 112017002963439-pat00071

Figure 112017002963439-pat00072

Figure 112017002963439-pat00073

Figure 112017002963439-pat00074

Figure 112017002963439-pat00075

Figure 112017002963439-pat00076

Figure 112017002963439-pat00077

Figure 112017002963439-pat00078

Figure 112017002963439-pat00079

Figure 112017002963439-pat00080

Figure 112017002963439-pat00081

Figure 112017002963439-pat00082

Figure 112017002963439-pat00083

본 발명에서 상기 화학식 1로 표시되는 화합물은 일반적인 합성방법에 따라 합성될 수 있다(Chem. Rev., 60:313 (1960); J. Chem. SOC. 4482 (1955); Chem. Rev. 95: 2457 (1995) 등 참조). 본 발명의 화합물에 대한 상세한 합성 과정은 후술하는 합성예에서 구체적으로 기술하도록 한다.The compound represented by Formula 1 of the present invention may be represented by the following compounds, but is not limited thereto:
Figure 112017002963439-pat00067

Figure 112017002963439-pat00068

Figure 112017002963439-pat00069

Figure 112017002963439-pat00070

Figure 112017002963439-pat00071

Figure 112017002963439-pat00072

Figure 112017002963439-pat00073

Figure 112017002963439-pat00074

Figure 112017002963439-pat00075

Figure 112017002963439-pat00076

Figure 112017002963439-pat00077

Figure 112017002963439-pat00078

Figure 112017002963439-pat00079

Figure 112017002963439-pat00080

Figure 112017002963439-pat00081

Figure 112017002963439-pat00082

Figure 112017002963439-pat00083

In the present invention, the compound represented by Formula 1 can be synthesized according to general synthetic methods (Chem. Rev., 60:313 (1960); J. Chem. SOC. 4482 (1955); Chem. Rev. 95: 2457 (1995), etc.). The detailed synthesis process for the compound of the present invention will be described in detail in the synthesis examples described later.

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

삭제delete

2. 유기 2. Organic 전계electric field 발광 소자 light emitting element

한편, 본 발명의 다른 측면은 상기한 본 발명에 따른 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자(유기 EL 소자)에 관한 것이다.Meanwhile, another aspect of the present invention relates to an organic electroluminescent device (organic EL device) containing the compound represented by Formula 1 according to the above-described present invention.

구체적으로, 본 발명은 양극(anode), 음극(cathode), 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함한다. 이때, 상기 화합물은 단독 또는 2 이상 혼합되어 사용될 수 있다.Specifically, the present invention is an organic electroluminescent device comprising an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, wherein at least one of the one or more organic material layers is It includes a compound represented by Formula 1 above. At this time, the above compounds may be used alone or in combination of two or more.

본 발명에 따른 유기 전계 발광 소자의 구조는 특별히 한정되지 않으며, 예컨대 기판, 양극, 정공 주입층, 정공 수송층, 발광층, 전자 수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 발광층과 전자 수송층 사이에는 전자 수송 보조층이 추가로 적층될 수 있고, 상기 전자 수송층 위에는 전자 주입층이 추가로 적층될 수 있다. 본 발명에서 상기 정공 주입층, 정공 수송층, 발광층, 발광 보조층, 수명 개선층, 전자 수송층, 전자 수송 보조층 및 전자 주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있다.The structure of the organic electroluminescent device according to the present invention is not particularly limited, and may be, for example, a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light-emitting layer, an electron transport layer, and a cathode are sequentially stacked. At this time, an electron transport auxiliary layer may be additionally laminated between the light emitting layer and the electron transport layer, and an electron injection layer may be additionally laminated on the electron transport layer. In the present invention, one or more of the hole injection layer, hole transport layer, light emitting layer, light emission auxiliary layer, lifespan improvement layer, electron transport layer, electron transport auxiliary layer, and electron injection layer may include the compound represented by Formula 1.

본 발명의 화학식 1로 표시되는 화합물은 트리아진을 축으로 Y자 형태의 기본 골격에 아릴기 및 헤테로아릴기와 같이 전자 흡수성이 큰 전자 끌개기(EWG)가 결합되어 분자 전체가 전자 이동도를 높일 수 있다. 즉, 본 발명의 화학식 1로 표시되는 화합물은 전자 이동도가 빨라 전자 수송층의 성능을 높여 이를 전자 수송층 또는 전자 수송 보조층의 재료로 사용하는 경우 유기 전계 발광 소자의 효율을 높일 수 있다. 또한, 발광층으로 엑시톤의 수 증가에 기여하여 발광 효율이 개선될 수 있으며, 소자의 내구성 및 안정성이 향상되어 소자의 수명 또한 효율적으로 증가될 수 있다.The compound represented by Formula 1 of the present invention has an electron withdrawing group (EWG) with high electron absorption, such as an aryl group and a heteroaryl group, bonded to a Y-shaped basic skeleton centered on a triazine, thereby increasing the electron mobility of the entire molecule. You can. That is, the compound represented by Formula 1 of the present invention has high electron mobility, so it can increase the performance of the electron transport layer and increase the efficiency of the organic electroluminescent device when used as a material for the electron transport layer or electron transport auxiliary layer. In addition, the emission efficiency can be improved by contributing to an increase in the number of excitons in the light-emitting layer, and the durability and stability of the device are improved, so the lifespan of the device can also be efficiently increased.

또, 본 발명의 유기 전계 발광 소자의 구조는 양극, 1층 이상의 유기물층 및 음극이 순차적으로 적층될 뿐만 아니라, 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.In addition, the structure of the organic electroluminescent device of the present invention may be one in which an anode, one or more organic material layers, and a cathode are sequentially stacked, and an insulating layer or adhesive layer is inserted at the interface between the electrode and the organic material layer.

본 발명의 유기 전계 발광 소자는 상기 유기물층 중 적어도 하나 이상(예컨대, 전자 수송층 또는 전자 수송 보조층)이 상기 화학식 1로 표시되는 화합물을 포함하도록 형성하는 것을 제외하고는, 당 기술 분야에 알려져 있는 재료 및 방법을 이용하여 다른 유기물층 및 전극을 형성하여 제조될 수 있다.The organic electroluminescent device of the present invention uses materials known in the art, except that at least one of the organic layers (e.g., an electron transport layer or an electron transport auxiliary layer) is formed to include the compound represented by Formula 1 above. and can be manufactured by forming other organic layers and electrodes using methods.

상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이에 한정되지 않는다.The organic material layer may be formed by vacuum deposition or solution application. Examples of the solution application method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer.

본 발명에서 사용 가능한 기판으로는 특별히 한정되지 않으며, 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등이 사용될 수 있다.There is no particular limitation on the substrate that can be used in the present invention, and silicon wafers, quartz, glass plates, metal plates, plastic films and sheets, etc. can be used.

또, 양극 물질로는 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등이 있으나, 이에 한정되지는 않는다.In addition, the anode material includes metals such as vanadium, chromium, copper, zinc, and gold, or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); Combinations of metals and oxides such as ZnO:Al or SnO 2 :Sb; Conductive polymers such as polythiophene, poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene] (PEDT), polypyrrole, or polyaniline; and carbon black, but are not limited thereto.

또, 음극 물질로는 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등이 있으나, 이에 한정되지는 않는다.Additionally, the cathode material includes metals such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead, or alloys thereof; and multilayer structure materials such as LiF/Al or LiO 2 /Al, etc., but are not limited thereto.

이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through examples. However, the following examples are merely illustrative of the present invention, and the present invention is not limited by the following examples.

[[ 준비예Preparation example 1] 2-(3,5- 1] 2-(3,5- 디브로모페닐Dibromophenyl )-4,6-디페닐-1,3,5-트리아진의 합성)-4,6-diphenyl-1,3,5-triazine synthesis

2-클로로-4,6-디페닐-1,3,5-트리아진 (100 g, 373.5 mmol)와 (3,5-디브로모페닐)보로닉산 (104.5 g, 373.5 mmol) 및 Pd(PPh3)4 (21.6 g, 18.6 mmol), K2CO3 (103.3 g, 747.0 mmol)을 톨루엔 1000ml, EtOH 200ml, H2O 200ml에 넣고 2시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 2-(3,5-디브로모페닐)-4,6-디페닐-1,3,5-트리아진 (104.7 g, 수율 60 %)을 얻었다.2-Chloro-4,6-diphenyl-1,3,5-triazine (100 g, 373.5 mmol) and (3,5-dibromophenyl)boronic acid (104.5 g, 373.5 mmol) and Pd(PPh) 3 ) 4 (21.6 g, 18.6 mmol) and K 2 CO 3 (103.3 g, 747.0 mmol) were added to 1000 ml of toluene, 200 ml of EtOH, and 200 ml of H 2 O and heated to reflux for 2 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (104.7 g, yield) 60%) was obtained.

1H-NMR: δ 7.40-7.41 (m, 4H), 7.51 (m, 4H), 7.96 (s, 1H), 8.27-8.28 (m, 4H) 1 H-NMR: δ 7.40-7.41 (m, 4H), 7.51 (m, 4H), 7.96 (s, 1H), 8.27-8.28 (m, 4H)

[LCMS] : 467[LCMS]: 467

[[ 준비예Preparation example 2] 6-(3- 2] 6-(3- 브로모bromo -5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) 페난트리딘의of phenanthridine 합성 synthesis

<단계 1> 6-(4,4,5,5-<Step 1> 6-(4,4,5,5- 테트라메틸tetramethyl -1,3,2--1,3,2- 디옥사보로란Dioxaborolan -2-일)-2 days) 페난트리딘의of phenanthridine 합성 synthesis

6-브로모페난트리딘 (15.4 g, 59.6 mmol)와 4,4,4',4',5,5,5',5'-옥타메틸-2,2'-비(1,3,2-디옥사보로란) (18.0 g, 70.8 mmol) 및 Pd(dppf)Cl2 (2.4 g, 3.0 mmol), KOAc (11.6 g, 118.8 mmol)을 1,4-디옥산 300ml에 넣고 12시간 동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)페난트리딘 (5.4 g, 수율 30 %)을 얻었다.6-bromophenanthridine (15.4 g, 59.6 mmol) and 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi(1,3,2 -Dioxabororane) (18.0 g, 70.8 mmol), Pd(dppf)Cl 2 (2.4 g, 3.0 mmol), and KOAc (11.6 g, 118.8 mmol) were added to 300ml of 1,4-dioxane and incubated for 12 hours. It was heated and refluxed. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenanthridine, was purified using column chromatography. (5.4 g, yield 30%) was obtained.

1H-NMR: δ 1.24 (s, 12H), 7.41-7.42 (m, 1H), 7.48-7.49(m, 1H), 7.59-7.60 (m, 1H), 7.76-7.78 (m, 2H), 7.92 (d, 1H), 7.98 (d, 1H), 8.06(d, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.41-7.42 (m, 1H), 7.48-7.49 (m, 1H), 7.59-7.60 (m, 1H), 7.76-7.78 (m, 2H), 7.92 (d, 1H), 7.98 (d, 1H), 8.06(d, 1H)

[LCMS] : 305[LCMS]: 305

<단계 2> 6-(3-<Step 2> 6-(3- 브로모bromo -5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) 페난트리딘의of phenanthridine 합성 synthesis

준비예 1에서 합성된 2-(3,5-디브로모페닐)-4,6-디페닐-1,3,5-트리아진 (7.6 g, 16.3 mmol)와 상기에서 합성된 6-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)페난트리딘 (5.0 g, 16.3 mmol) 및 Pd(PPh3)4 (0.9 g, 0.8 mmol), K2CO3 (4.5 g, 32.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)페난트리딘 (6.4 g, 수율 70 %)을 얻었다.2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (7.6 g, 16.3 mmol) synthesized in Preparation Example 1 and 6-(4 synthesized above ,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)phenanthridine (5.0 g, 16.3 mmol) and Pd(PPh 3 ) 4 (0.9 g, 0.8 mmol) , K 2 CO 3 (4.5 g, 32.6 mmol) was added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) was purified using column chromatography. Phenanthridine (6.4 g, yield 70%) was obtained.

1H-NMR: δ 7.41-7.42 (m, 3H), 7.48-7.49 (m, 2H), 7.50-7.51 (m, 4H), 7.59-7.60 (m, 1H), 7.76-7.78 (m, 2H), 7.92-7.93 (m, 2H), 7.98 (d, 1H), 8.06 (s, 1H), 8.15 (s, 1H), 8.27-8.28 (m, 4H) 1 H-NMR: δ 7.41-7.42 (m, 3H), 7.48-7.49 (m, 2H), 7.50-7.51 (m, 4H), 7.59-7.60 (m, 1H), 7.76-7.78 (m, 2H) , 7.92-7.93 (m, 2H), 7.98 (d, 1H), 8.06 (s, 1H), 8.15 (s, 1H), 8.27-8.28 (m, 4H)

[LCMS] : 565[LCMS] : 565

[[ 준비예Preparation example 3] 5- 3] 5- (3-브로모-5-(3-Bromo-5- (4,6-디페닐-1,3,5-트리아진-2-일)페닐)(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) 벤조[c][2,7]나프티리딘의Benzo[c][2,7]naphthyridine 합성 synthesis

<단계 1> 5-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)벤조[c][2,7]나프티리딘의 합성<Step 1> Synthesis of 5-(4,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)benzo[c][2,7]naphthyridine

5-브로모벤조[c][2,7]나프티리딘 (15.4 g, 59.6 mmol)와 4,4,4',4',5,5,5',5'-옥타메틸-2,2'-비(1,3,2-디옥사보로란) (18.0 g, 70.8 mmol) 및 Pd(dppf)Cl2 (2.4 g, 3.0 mmol), KOAc (11.6 g, 118.8 mmol)을 1,4-디옥산 300ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)벤조[c][2,7]나프티리딘 (5.6 g, 수율 35 %)을 얻었다.5-Bromobenzo[c][2,7]naphthyridine (15.4 g, 59.6 mmol) and 4,4,4',4',5,5,5',5'-octamethyl-2,2' -Bi(1,3,2-dioxabororane) (18.0 g, 70.8 mmol) and Pd(dppf)Cl 2 (2.4 g, 3.0 mmol) and KOAc (11.6 g, 118.8 mmol) were added to 1,4- It was added to 300ml of dioxane and heated to reflux for 12 hours. After completion of the reaction, it was extracted with methylene chloride, MgSO 4 was added, and filtered. After removing the solvent in the filtered organic layer, the target compound, 5-(4,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)benzo[c ][2,7]naphthyridine (5.6 g, yield 35%) was obtained.

1H-NMR: δ 1.24 (s, 12H), 7.38 (d, 1H), 7.60 (t, 1H), 7.78 (t, 1H), 7.96 (d, 1H), 8.06(d, 1H), 8.43(d, 1H), 9.51 (s, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.38 (d, 1H), 7.60 (t, 1H), 7.78 (t, 1H), 7.96 (d, 1H), 8.06 (d, 1H), 8.43 ( d, 1H), 9.51 (s, 1H)

[LCMS] : 306 [LCMS]: 306

<단계 2> 5-<Step 2> 5- (3-브로모-5-(3-Bromo-5- (4,6-디페닐-1,3,5-트리아진-2-일)페닐)(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) 벤조[c][2,7]나프티리딘의Benzo[c][2,7]naphthyridine 합성 synthesis

준비예 1에서 합성된 2-(3,5-디브로모페닐)-4,6-디페닐-1,3,5-트리아진 (7.6 g, 16.3 mmol)와 상기에서 합성된 5-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)벤조[c][2,7]나프티리딘 (5.0 g, 16.3 mmol) 및 Pd(PPh3)4 (0.9 g, 0.8 mmol), K2CO3 (4.5 g, 32.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)벤조[c][2,7]나프티리딘 (6.0 g, 수율 65 %)을 얻었다.2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (7.6 g, 16.3 mmol) synthesized in Preparation Example 1 and 5-(4 synthesized above ,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)benzo[c][2,7]naphthyridine (5.0 g, 16.3 mmol) and Pd(PPh 3 ) 4 (0.9 g, 0.8 mmol) and K 2 CO 3 (4.5 g, 32.6 mmol) were added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 5-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) was purified using column chromatography. Benzo[c][2,7]naphthyridine (6.0 g, yield 65%) was obtained.

1H-NMR: δ 7.38 (d, 1H), 7.41-7.42 (m, 2H), 7.48 (s, 1H), 7.50-7.51 (m, 4H), 7.60-7.61 (m, 1H), 7.78 (t, 1H), 7.93 (s, 1H), 7.98 (d, 1H), 8.08 (d, 1H), 8.15 (s, 1H), 8.27-8.28 (m, 4H), 8.43 (d, 1H), 9.34 (s, 1H) 1 H-NMR: δ 7.38 (d, 1H), 7.41-7.42 (m, 2H), 7.48 (s, 1H), 7.50-7.51 (m, 4H), 7.60-7.61 (m, 1H), 7.78 (t , 1H), 7.93 (s, 1H), 7.98 (d, 1H), 8.08 (d, 1H), 8.15 (s, 1H), 8.27-8.28 (m, 4H), 8.43 (d, 1H), 9.34 ( s, 1H)

[LCMS] : 566[LCMS] : 566

[[ 준비예Preparation example 4] 6- 4] 6- (3-브로모-5-(3-Bromo-5- (4,6-디페닐-1,3,5-트리아진-2-일)페닐)(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) 피리도[3,2-f]퀴녹살린의Pyrido[3,2-f]quinoxaline 합성 synthesis

<단계 1> 6-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)피리도[3,2-f]퀴녹살린의 합성<Step 1> Synthesis of 6-(4,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)pyrido[3,2-f]quinoxaline

6-브로모피리도[3,2-f]퀴녹살린 (15.4 g, 59.6 mmol)와 4,4,4',4',5,5,5',5'-옥타메틸-2,2'-비(1,3,2-디옥사보로란) (18.0 g, 70.8 mmol) 및 Pd(dppf)Cl2 (2.4 g, 3.0 mmol), KOAc (11.6 g, 118.8 mmol)을 1,4-디옥산 300ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)피리도[3,2-f]퀴녹살린 (8.8 g, 수율 49 %)을 얻었다.6-Bromopyrido[3,2-f]quinoxaline (15.4 g, 59.6 mmol) and 4,4,4',4',5,5,5',5'-octamethyl-2,2'- B(1,3,2-dioxabororane) (18.0 g, 70.8 mmol) and Pd(dppf)Cl 2 (2.4 g, 3.0 mmol) and KOAc (11.6 g, 118.8 mmol) were reacted with 1,4-dioxabororane (18.0 g, 70.8 mmol). It was added to 300ml of oxalic acid and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido [ 3,2-f]quinoxaline (8.8 g, yield 49%) was obtained.

1H-NMR: δ 1.24 (s, 12H), 7.58 (t, 1H), 8.06(d, 1H), 8.38(d, 1H), 8.70 (s, 2H), 8.83(d, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.58 (t, 1H), 8.06 (d, 1H), 8.38 (d, 1H), 8.70 (s, 2H), 8.83 (d, 1H)

[LCMS] : 307 [LCMS] : 307

<단계 2> 6-<Step 2> 6- (3-브로모-5-(3-Bromo-5- (4,6-디페닐-1,3,5-트리아진-2-일)페닐)(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) 피리도[3,2-f]퀴녹살린의Pyrido[3,2-f]quinoxaline 합성 synthesis

준비예 1에서 합성된 2-(3,5-디브로모페닐)-4,6-디페닐-1,3,5-트리아진 (7.6 g, 16.3 mmol)와 상기에서 합성된 6-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)피리도[3,2-f]퀴녹살린 (5.0 g, 16.3 mmol) 및 Pd(PPh3)4 (0.9 g, 0.8 mmol), K2CO3 (4.5 g, 32.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[3,2-f]퀴녹살린 (5.5 g, 수율 60 %)을 얻었다.2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (7.6 g, 16.3 mmol) synthesized in Preparation Example 1 and 6-(4 synthesized above ,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)pyrido[3,2-f]quinoxaline (5.0 g, 16.3 mmol) and Pd(PPh 3 ) 4 (0.9 g, 0.8 mmol) and K 2 CO 3 (4.5 g, 32.6 mmol) were added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) was purified using column chromatography. Pyrido[3,2-f]quinoxaline (5.5 g, yield 60%) was obtained.

1H-NMR: δ 7.41-7.42 (m, 4H), 7.50-7.51 (m, 4H), 7.58 (t, 1H), 7.64 (s, 1H), 8.28-8.29 (m, 5H), 8.38 (d, 1H), 8.74 (s, 2H), 8.83 (d, 1H) 1 H-NMR: δ 7.41-7.42 (m, 4H), 7.50-7.51 (m, 4H), 7.58 (t, 1H), 7.64 (s, 1H), 8.28-8.29 (m, 5H), 8.38 (d) , 1H), 8.74 (s, 2H), 8.83 (d, 1H)

[LCMS] : 567[LCMS]: 567

[[ 준비예Preparation example 5] 6- 5] 6- (3-브로모-5-(3-Bromo-5- (4,6-디페닐-1,3,5-트리아진-2-일)페닐)(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) 피리도[4,3-c][1,5]나프티리딘의of pyrido[4,3-c][1,5]naphthyridine. 합성 synthesis

<단계 1> 6-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)피리도[4,3-c][1,5]나프티리딘의 합성<Step 1> 6-(4,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)pyrido[4,3-c][1,5]naphthyridine synthesis of

6-브로모피리도[4,3-c][1,5]나프티리딘 (15.4 g, 59.6 mmol)와 4,4,4',4',5,5,5',5'-옥타메틸-2,2'-비(1,3,2-디옥사보로란) (18.0 g, 70.8 mmol) 및 Pd(dppf)Cl2 (2.4 g, 3.0 mmol), KOAc (11.6 g, 118.8 mmol)을 1,4-디옥산 300ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)피리도[4,3-c][1,5]나프티리딘 (5.4 g, 수율 30 %)을 얻었다.6-Bromopyrido[4,3-c][1,5]naphthyridine (15.4 g, 59.6 mmol) and 4,4,4',4',5,5,5',5'-octamethyl- 2,2'-bi(1,3,2-dioxabororane) (18.0 g, 70.8 mmol) and Pd(dppf)Cl 2 (2.4 g, 3.0 mmol), KOAc (11.6 g, 118.8 mmol) It was added to 300ml of 1,4-dioxane and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrido [ 4,3-c][1,5]naphthyridine (5.4 g, yield 30%) was obtained.

1H-NMR: δ 1.24 (s, 12H), 7.78 (d, 1H), 7.91 (t, 1H), 8.50(d, 1H), 8.75(d, 1H), 9.10 (d, 1H), 9.39 (s, 1H) 1 H-NMR: δ 1.24 (s, 12H), 7.78 (d, 1H), 7.91 (t, 1H), 8.50 (d, 1H), 8.75 (d, 1H), 9.10 (d, 1H), 9.39 ( s, 1H)

[LCMS] : 307 [LCMS] : 307

<단계 2> 6-<Step 2> 6- (3-브로모-5-(3-Bromo-5- (4,6-디페닐-1,3,5-트리아진-2-일)페닐)(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) 피리도[4,3-c][1,5]나프티리딘의of pyrido[4,3-c][1,5]naphthyridine. 합성 synthesis

준비예 1에서 합성된 2-(3,5-디브로모페닐)-4,6-디페닐-1,3,5-트리아진 (7.6 g, 16.3 mmol)와 상기에서 합성된 6-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)피리도[4,3-c][1,5]나프티리딘 (5.0 g, 16.3 mmol) 및 Pd(PPh3)4 (0.9 g, 0.8 mmol), K2CO3 (4.5 g, 32.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[4,3-c][1,5]나프티리딘 (5.5 g, 수율 60 %)을 얻었다.2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (7.6 g, 16.3 mmol) synthesized in Preparation Example 1 and 6-(4 synthesized above ,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)pyrido[4,3-c][1,5]naphthyridine (5.0 g, 16.3 mmol) and Pd(PPh 3 ) 4 (0.9 g, 0.8 mmol) and K 2 CO 3 (4.5 g, 32.6 mmol) were added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) was purified using column chromatography. Pyrido[4,3-c][1,5]naphthyridine (5.5 g, yield 60%) was obtained.

1H-NMR: δ 7.41-7.42 (m, 2H), 7.48 (s, 1H), 7.50-7.51 (m, 4H), 7.78 (d, 1H), 7.91-7.93 (m, 2H), 8.15 (s, 1H), 8.27-8.28 (m, 4H), 8.50 (s, 1H), 8.75 (d, 1H), 9.10 (d, 1H), 9.39 (s, 1H) 1 H-NMR: δ 7.41-7.42 (m, 2H), 7.48 (s, 1H), 7.50-7.51 (m, 4H), 7.78 (d, 1H), 7.91-7.93 (m, 2H), 8.15 (s) , 1H), 8.27-8.28 (m, 4H), 8.50 (s, 1H), 8.75 (d, 1H), 9.10 (d, 1H), 9.39 (s, 1H)

[LCMS] : 567[LCMS]: 567

[[ 준비예Preparation example 6] 4-(3- 6] 4-(3- 브로모bromo -5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-1,10-페난트롤린의 합성Synthesis of -5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-1,10-phenanthroline

<단계 1> 4-(4,4,5,5-<Step 1> 4-(4,4,5,5- 테트라메틸tetramethyl -1,3,2--1,3,2- 디옥사보로란Dioxaborolan -2-일)-1,10-페난트롤린의 합성-2-day) Synthesis of -1,10-phenanthroline

4-브로모-1,10-페난트롤린 (15.4 g, 59.6 mmol)와 4,4,4',4',5,5,5',5'-옥타메틸-2,2'-bi(1,3,2-디옥사보로란) (18.0 g, 70.8 mmol) 및 Pd(dppf)Cl2 (2.4 g, 3.0 mmol), KOAc (11.6 g, 118.8 mmol)을 1,4-디옥산 300ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-1,10-페난트롤린 (8.6 g, 수율 49 %)을 얻었다.4-Bromo-1,10-phenanthroline (15.4 g, 59.6 mmol) and 4,4,4',4',5,5,5',5'-octamethyl-2,2'-bi( 1,3,2-dioxabororane) (18.0 g, 70.8 mmol), Pd(dppf)Cl 2 (2.4 g, 3.0 mmol), and KOAc (11.6 g, 118.8 mmol) were added to 300ml of 1,4-dioxane. and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 4-(4,4,5,5-tetramethyl-1,3,2-dioxabororan-2-yl)-1, 10-phenanthroline (8.6 g, yield 49%) was obtained.

1H-NMR: δ 1.24 (s, 12H), 7.48 (d, 1H), 7.58 (t, 1H), 7.81 (d, 1H), 8.06 (d, 1H), 8.38(d, 1H), 8.83(d, 2H) 1 H-NMR: δ 1.24 (s, 12H), 7.48 (d, 1H), 7.58 (t, 1H), 7.81 (d, 1H), 8.06 (d, 1H), 8.38(d, 1H), 8.83( d, 2H)

[LCMS] : 306[LCMS]: 306

<단계 2> 4-(3-<Step 2> 4-(3- 브로모bromo -5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-1,10-페난트롤린의 합성Synthesis of -5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-1,10-phenanthroline

준비예 1에서 합성된 2-(3,5-디브로모페닐)-4,6-디페닐-1,3,5-트리아진 (7.6 g, 16.3 mmol)와 상기에서 합성된 4-(4,4,5,5-테트라메틸-1,3,2-디옥사보로란-2-일)-1,10-페난트롤린 (5.0 g, 16.3 mmol) 및 Pd(PPh3)4 (0.9 g, 0.8 mmol), K2CO3 (4.5 g, 32.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-1,10-페난트롤린 (6.0 g, 수율 65 %)을 얻었다.2-(3,5-dibromophenyl)-4,6-diphenyl-1,3,5-triazine (7.6 g, 16.3 mmol) synthesized in Preparation Example 1 and 4-(4 synthesized above ,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,10-phenanthroline (5.0 g, 16.3 mmol) and Pd(PPh 3 ) 4 (0.9 g, 0.8 mmol), K 2 CO 3 (4.5 g, 32.6 mmol) were added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 4-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl) was purified using column chromatography. -1,10-phenanthroline (6.0 g, yield 65%) was obtained.

1H-NMR: δ 7.41-7.42 (m, 4H), 7.48 (d, 1H), 7.50-7.51 (m, 4H), 7.58 (t, 1H), 7.64 (s, 1H),7.81 (d, 1H), 8.06 (d, 1H), 8.27-8.28 (m, 4H), 8.38 (d, 1H), 8.83 (d, 1H), 8.89 (d, 1H) 1 H-NMR: δ 7.41-7.42 (m, 4H), 7.48 (d, 1H), 7.50-7.51 (m, 4H), 7.58 (t, 1H), 7.64 (s, 1H), 7.81 (d, 1H) ), 8.06 (d, 1H), 8.27-8.28 (m, 4H), 8.38 (d, 1H), 8.83 (d, 1H), 8.89 (d, 1H)

[LCMS] : 566[LCMS] : 566

[[ 합성예Synthesis example 1] 화합물 1의 합성 1] Synthesis of Compound 1

준비예 2의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)페난트리딘 (5 g, 8.8 mmol)와 페닐 보로닉산 (1.2 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(5-(4,6-디페닐-1,3,5-트리아진-2-일)-[1,1'-비페닐]-3-일)페난트리딘 (3.4 g, 수율 70 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)phenanthridine (5 g, 8.8 mmol) and phenyl boro of Preparation Example 2 Ninic acid (1.2 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), and K 2 CO 3 (2.4 g, 17.6 mmol) were added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O for 12 hours. It was heated and refluxed. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(5-(4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1'- Biphenyl]-3-yl)phenanthridine (3.4 g, yield 70%) was obtained.

[LCMS] : 562[LCMS] : 562

[[ 합성예Synthesis example 2] 화합물 8 합성 2] Synthesis of compound 8

준비예 2의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)페난트리딘 (5 g, 8.8 mmol)와 나프탈렌-2-일보로닉산 (1.7 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(나프탈렌-2-일)페닐)페난트리딘 (3.9 g, 수율 73 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)phenanthridine (5 g, 8.8 mmol) of Preparation Example 2 and naphthalene- 2-ylboronic acid (1.7 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), and K 2 CO 3 (2.4 g, 17.6 mmol) were added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O. It was added and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(naphthalene-2, was purified using column chromatography. -yl)phenyl)phenanthridine (3.9 g, yield 73%) was obtained.

[LCMS] : 612[LCMS] : 612

[[ 합성예Synthesis example 3] 화합물 17의 합성 3] Synthesis of Compound 17

준비예 2의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)페난트리딘 (5 g, 8.8 mmol)와 (9,9-디메틸-9H-플루오렌-2-일)보로닉산 (2.3 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-(9,9-디메틸-9H-플루오렌-2-일)-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)페난트리딘 (4.2 g, 수율 71 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)phenanthridine (5 g, 8.8 mmol) and (9) of Preparation Example 2 ,9-dimethyl-9H-fluoren-2-yl)boronic acid (2.3 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) It was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-(9,9-dimethyl-9H-fluoren-2-yl)-5-(4,6-diphenyl-1, was purified using column chromatography. , 3,5-triazin-2-yl) phenyl) phenanthridine (4.2 g, yield 71%) was obtained.

[LCMS] : 678[LCMS] : 678

[[ 합성예Synthesis example 4] 화합물 29의 합성 4] Synthesis of compound 29

준비예 2의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)페난트리딘 (5 g, 8.8 mmol)와 (9,9-디페닐-9H-플루오렌-4-일)보로닉산 (3.5 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(9,9-디페닐-9H-플루오렌-4-일)페닐)페난트리딘 (4.6 g, 수율 65 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)phenanthridine (5 g, 8.8 mmol) and (9) of Preparation Example 2 ,9-diphenyl-9H-fluoren-4-yl)boronic acid (3.5 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(9,9) was purified using column chromatography. -Diphenyl-9H-fluoren-4-yl)phenyl)phenanthridine (4.6 g, yield 65%) was obtained.

[LCMS] : 802[LCMS] : 802

[[ 합성예Synthesis example 5] 화합물 89의 합성 5] Synthesis of compound 89

준비예 3의 5-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)벤조[c][2,7]나프티리딘 (5 g, 8.8 mmol)와 페닐 보로닉산 (1.2 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(5-(4,6-디페닐-1,3,5-트리아진-2-일)-[1,1'-비페닐]-3-일)벤조[c][2,7]나프티리딘 (3.4 g, 수율 70 %)을 얻었다.5-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)benzo[c][2,7]naphthyridine (5) of Preparation Example 3 g, 8.8 mmol), phenylboronic acid (1.2 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) in 200 ml of toluene, 40 ml of EtOH, H 2 O was added to 40ml and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 5-(5-(4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1'- Biphenyl]-3-yl)benzo[c][2,7]naphthyridine (3.4 g, yield 70%) was obtained.

[LCMS] : 563[LCMS] : 563

[[ 합성예Synthesis example 6] 화합물 96 합성 6] Synthesis of compound 96

준비예 3의 5-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)벤조[c][2,7]나프티리딘 (5 g, 8.8 mmol)와 나프탈렌-2-일보로닉산 (1.7 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(나프탈렌-2-일)페닐)벤조[c][2,7]나프티리딘 (3.9 g, 수율 73 %)을 얻었다.5-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)benzo[c][2,7]naphthyridine (5) of Preparation Example 3 g, 8.8 mmol), naphthalene-2-ylboronic acid (1.7 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) in 200 ml of toluene, It was added to 40ml of EtOH and 40ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 5-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(naphthalene-2, was purified using column chromatography. -yl)phenyl)benzo[c][2,7]naphthyridine (3.9 g, yield 73%) was obtained.

[LCMS] : 613[LCMS] : 613

[[ 합성예Synthesis example 7] 화합물 105의 합성 7] Synthesis of Compound 105

준비예 3의 5-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)벤조[c][2,7]나프티리딘 (5 g, 8.8 mmol)와 (9,9-디메틸-9H-플루오렌-2-일)보로닉산 (2.3 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(3-(9,9-디메틸-9H-플루오렌-2-일)-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)벤조[c][2,7]나프티리딘 (4.2 g, 수율 71 %)을 얻었다.5-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)benzo[c][2,7]naphthyridine (5) of Preparation Example 3 g, 8.8 mmol) and (9,9-dimethyl-9H-fluoren-2-yl)boronic acid (2.3 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 5-(3-(9,9-dimethyl-9H-fluoren-2-yl)-5-(4,6-diphenyl-1, was purified using column chromatography. ,3,5-triazin-2-yl)phenyl)benzo[c][2,7]naphthyridine (4.2 g, yield 71%) was obtained.

[LCMS] : 679[LCMS] : 679

[[ 합성예Synthesis example 8] 화합물 117의 합성 8] Synthesis of compound 117

준비예 3의 5-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)벤조[c][2,7]나프티리딘 (5 g, 8.8 mmol)와 (9,9-디페닐-9H-플루오렌-4-일)보로닉산 (3.5 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(9,9-디페닐-9H-플루오렌-4-일)페닐)벤조[c][2,7]나프티리딘 (4.6 g, 수율 65 %)을 얻었다.5-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)benzo[c][2,7]naphthyridine (5) of Preparation Example 3 g, 8.8 mmol) and (9,9-diphenyl-9H-fluoren-4-yl)boronic acid (3.5 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 5-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(9,9) was purified using column chromatography. -Diphenyl-9H-fluoren-4-yl)phenyl)benzo[c][2,7]naphthyridine (4.6 g, yield 65%) was obtained.

[LCMS] : 803[LCMS] : 803

[[ 합성예Synthesis example 9] 화합물 177의 합성 9] Synthesis of compound 177

준비예 4의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[3,2-f]퀴녹살린 (5 g, 8.8 mmol)와 페닐 보로닉산 (1.2 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(5-(4,6-디페닐-1,3,5-트리아진-2-일)-[1,1'-비페닐]-3-일)피리도[3,2-f]퀴녹살린 (3.4 g, 수율 70 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyrido[3,2-f]quinoxaline (5) of Preparation Example 4 g, 8.8 mmol), phenylboronic acid (1.2 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) in 200 ml of toluene, 40 ml of EtOH, H 2 O was added to 40ml and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(5-(4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1'- Biphenyl]-3-yl)pyrido[3,2-f]quinoxaline (3.4 g, yield 70%) was obtained.

[LCMS] : 564[LCMS] : 564

[[ 합성예Synthesis example 10] 화합물 184 합성 10] Synthesis of compound 184

준비예 4의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[3,2-f]퀴녹살린 (5 g, 8.8 mmol)와 나프탈렌-2-일보로닉산 (1.7 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(나프탈렌-2-일)페닐)피리도[3,2-f]퀴녹살린 (3.9 g, 수율 73 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyrido[3,2-f]quinoxaline (5) of Preparation Example 4 g, 8.8 mmol), naphthalene-2-ylboronic acid (1.7 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) in 200 ml of toluene, It was added to 40ml of EtOH and 40ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(naphthalene-2, was purified using column chromatography. -yl)phenyl)pyrido[3,2-f]quinoxaline (3.9 g, yield 73%) was obtained.

[LCMS] : 614[LCMS] : 614

[[ 합성예Synthesis example 11] 화합물 193의 합성 11] Synthesis of compound 193

준비예 4의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[3,2-f]퀴녹살린 (5 g, 8.8 mmol)와 (9,9-디메틸-9H-플루오렌-2-일)보로닉산 (2.3 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-(9,9-디메틸-9H-플루오렌-2-일)-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[3,2-f]퀴녹살린 (4.2 g, 수율 71 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyrido[3,2-f]quinoxaline (5) of Preparation Example 4 g, 8.8 mmol) and (9,9-dimethyl-9H-fluoren-2-yl)boronic acid (2.3 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, it was extracted with methylene chloride, MgSO 4 was added, and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-(9,9-dimethyl-9H-fluoren-2-yl)-5-(4,6-diphenyl-1, was purified using column chromatography. , 3,5-triazin-2-yl) phenyl) pyrido [3,2-f] quinoxaline (4.2 g, yield 71%) was obtained.

[LCMS] : 680[LCMS] : 680

[[ 합성예Synthesis example 12] 화합물 195의 합성 12] Synthesis of compound 195

준비예 4의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[3,2-f]퀴녹살린 (5 g, 8.8 mmol)와 (9,9-디페닐-9H-플루오렌-2-일)보로닉산 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(9,9-디페닐-9H-플루오렌-2-일)페닐)피리도[3,2-f]퀴녹살린 (4.6 g, 수율 65 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyrido[3,2-f]quinoxaline (5) of Preparation Example 4 g, 8.8 mmol) and (9,9-diphenyl-9H-fluoren-2-yl)boronic acid and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) ) was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(9,9) was purified using column chromatography. -Diphenyl-9H-fluoren-2-yl)phenyl)pyrido[3,2-f]quinoxaline (4.6 g, yield 65%) was obtained.

[LCMS] : 804[LCMS]: 804

[[ 합성예Synthesis example 13] 화합물 209의 합성 13] Synthesis of compound 209

준비예 5의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[4,3-c][1,5]나프티리딘 (5 g, 8.8 mmol)와 페닐 보로닉산 (1.2 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(5-(4,6-디페닐-1,3,5-트리아진-2-일)-[1,1'-비페닐]-3-일)피리도[4,3-c][1,5]나프티리딘 (3.4 g, 수율 70 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyrido[4,3-c][1,5 of Preparation Example 5 ]Naphthyridine (5 g, 8.8 mmol), phenylboronic acid (1.2 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), and K 2 CO 3 (2.4 g, 17.6 mmol) were dissolved in 200 ml of toluene. , 40ml of EtOH and 40ml of H 2 O were added and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(5-(4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1'- Biphenyl]-3-yl)pyrido[4,3-c][1,5]naphthyridine (3.4 g, yield 70%) was obtained.

[LCMS] : 564[LCMS] : 564

[[ 합성예Synthesis example 14] 화합물 213의 합성 14] Synthesis of compound 213

준비예 5의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[4,3-c][1,5]나프티리딘 (5 g, 8.8 mmol)와 [1,1'-비페닐]-4-일보로닉산 (1.9 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(5-(4,6-디페닐-1,3,5-트리아진-2-일)-[1,1':4',1''-터페닐]-3-일)피리도[4,3-c][1,5]나프티리딘 (2.8 g, 수율 50 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyrido[4,3-c][1,5 of Preparation Example 5 ]naphthyridine (5 g, 8.8 mmol) and [1,1'-biphenyl]-4-ylboronic acid (1.9 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) was added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(5-(4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1': 4',1''-terphenyl]-3-yl)pyrido[4,3-c][1,5]naphthyridine (2.8 g, yield 50%) was obtained.

[LCMS] : 640[LCMS] : 640

[[ 합성예Synthesis example 15] 화합물 214 합성 15] Synthesis of compound 214

준비예 5의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[4,3-c][1,5]나프티리딘 (5 g, 8.8 mmol)와 [1,1'-비페닐]-3-일보로닉산 (1.9 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(5-(4,6-디페닐-1,3,5-트리아진-2-일)-[1,1':3',1''-터페닐]-3-일)피리도[4,3-c][1,5]나프티리딘 (2.8 g, 수율 50 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyrido[4,3-c][1,5 of Preparation Example 5 ]naphthyridine (5 g, 8.8 mmol) and [1,1'-biphenyl]-3-ylboronic acid (1.9 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) was added to 200 ml of toluene, 40 ml of EtOH, and 40 ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(5-(4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1': 3',1''-terphenyl]-3-yl)pyrido[4,3-c][1,5]naphthyridine (2.8 g, yield 50%) was obtained.

[LCMS] : 640[LCMS] : 640

[[ 합성예Synthesis example 16] 화합물 216 합성 16] Synthesis of compound 216

준비예 5의 6-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)피리도[4,3-c][1,5]나프티리딘 (5 g, 8.8 mmol)와 나프탈렌-2-일보로닉산 (1.7 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(나프탈렌-2-일)페닐)피리도[4,3-c][1,5]나프티리딘 (3.9 g, 수율 73 %)을 얻었다.6-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)pyrido[4,3-c][1,5 of Preparation Example 5 ]naphthyridine (5 g, 8.8 mmol), naphthalene-2-ylboronic acid (1.7 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) ) was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, it was extracted with methylene chloride, MgSO 4 was added, and filtered. After removing the solvent in the filtered organic layer, the target compound, 6-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(naphthalene-2, was purified using column chromatography. -yl)phenyl)pyrido[4,3-c][1,5]naphthyridine (3.9 g, yield 73%) was obtained.

[LCMS] : 614[LCMS] : 614

[[ 합성예Synthesis example 17] 화합물 225의 합성 17] Synthesis of compound 225

준비예 6의 4-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-1,10-페난트롤린 (5 g, 8.8 mmol)와 페닐 보로닉산 (1.2 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(5-(4,6-디페닐-1,3,5-트리아진-2-일)-[1,1'-비페닐]-3-일)-1,10-페난트롤린 (3.4 g, 수율 370 %)을 얻었다.4-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-1,10-phenanthroline of Preparation Example 6 (5 g, 8.8 mmol), phenylboronic acid (1.2 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) in 200 ml of toluene, 40 ml of EtOH, 40 ml of H 2 O. and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 4-(5-(4,6-diphenyl-1,3,5-triazin-2-yl)-[1,1'- Biphenyl]-3-yl)-1,10-phenanthroline (3.4 g, yield 370%) was obtained.

[LCMS] : 563[LCMS] : 563

[[ 합성예Synthesis example 18] 화합물 226 합성 18] Synthesis of compound 226

준비예 6의 4-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-1,10-페난트롤린 (5 g, 8.8 mmol)와 나프탈렌-2-일보로닉산 (1.7 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(나프탈렌-2-일)페닐)-1,10-페난트롤린 (3.9 g, 수율 73 %)을 얻었다.4-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-1,10-phenanthroline of Preparation Example 6 (5 g, 8.8 mmol) and naphthalene-2-ylboronic acid (1.7 g, 9.7 mmol), Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), and K 2 CO 3 (2.4 g, 17.6 mmol) were dissolved in 200 ml of toluene, 40 ml of EtOH, It was added to 40ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 4-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(naphthalene-2, was purified using column chromatography. -yl)phenyl)-1,10-phenanthroline (3.9 g, yield 73%) was obtained.

[LCMS] : 613[LCMS] : 613

[[ 합성예Synthesis example 19] 화합물 227의 합성 19] Synthesis of compound 227

준비예 6의 4-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-1,10-페난트롤린 (5 g, 8.8 mmol)와 (9,9-디메틸-9H-플루오렌-2-일)보로닉산 (2.3 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(3-(9,9-디메틸-9H-플루오렌-2-일)-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-1,10-페난트롤린 (4.2 g, 수율 71 %)을 얻었다.4-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-1,10-phenanthroline of Preparation Example 6 (5 g, 8.8 mmol) and (9,9-dimethyl-9H-fluoren-2-yl)boronic acid (2.3 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g , 17.6 mmol) was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, the extract was extracted with methylene chloride, MgSO 4 was added and filtered. After removing the solvent in the filtered organic layer, the target compound, 4-(3-(9,9-dimethyl-9H-fluoren-2-yl)-5-(4,6-diphenyl-1, was purified using column chromatography. ,3,5-triazin-2-yl)phenyl)-1,10-phenanthroline (4.2 g, yield 71%) was obtained.

[LCMS] : 679[LCMS] : 679

[[ 합성예Synthesis example 20] 화합물 228의 합성 20] Synthesis of compound 228

준비예 6의 4-(3-브로모-5-(4,6-디페닐-1,3,5-트리아진-2-일)페닐)-1,10-페난트롤린 (5 g, 8.8 mmol)와 (9,9-디페닐-9H-플루오렌-4-일)보로닉산 (3.5 g, 9.7 mmol) 및 Pd(PPh3)4 (0.5 g, 0.4 mmol), K2CO3 (2.4 g, 17.6 mmol)을 톨루엔 200ml, EtOH 40ml, H2O 40ml에 넣고 12시간 동안 가열 환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(3-(4,6-디페닐-1,3,5-트리아진-2-일)-5-(9,9-디페닐-9H-플루오렌-4-일)페닐)-1,10-페난트롤린 (4.6 g, 수율 65 %)을 얻었다.4-(3-bromo-5-(4,6-diphenyl-1,3,5-triazin-2-yl)phenyl)-1,10-phenanthroline of Preparation Example 6 (5 g, 8.8 mmol) and (9,9-diphenyl-9H-fluoren-4-yl)boronic acid (3.5 g, 9.7 mmol) and Pd(PPh 3 ) 4 (0.5 g, 0.4 mmol), K 2 CO 3 (2.4 g, 17.6 mmol) was added to 200ml of toluene, 40ml of EtOH, and 40ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, it was extracted with methylene chloride, MgSO 4 was added, and filtered. After removing the solvent in the filtered organic layer, the target compound, 4-(3-(4,6-diphenyl-1,3,5-triazin-2-yl)-5-(9,9) was purified using column chromatography. -Diphenyl-9H-fluoren-4-yl)phenyl)-1,10-phenanthroline (4.6 g, yield 65%) was obtained.

[LCMS] : 803[LCMS] : 803

[[ 실시예Example 1 ~ 20] 청색 유기 1 to 20] Blue Organic 전계electric field 발광 소자의 제작 Fabrication of light emitting devices

합성예에서 합성된 화합물 1, 8, 17, 29, 89, 96, 105, 117, 177, 184, 193, 195, 209, 213, 214, 216, 225, 226, 227, 228을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 하기와 같이 청색 유기 전계 발광 소자를 제작하였다.Compounds 1, 8, 17, 29, 89, 96, 105, 117, 177, 184, 193, 195, 209, 213, 214, 216, 225, 226, 227, and 228 synthesized in the synthesis examples are commonly known methods. After high-purity sublimation purification, a blue organic electroluminescent device was manufactured as follows.

먼저, ITO (Indium tin oxide)가 1500 Å 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, a glass substrate coated with a 1500 Å thin film of ITO (indium tin oxide) was washed with distilled water ultrasonic waves. After cleaning with distilled water, ultrasonic cleaning with solvents such as isopropyl alcohol, acetone, and methanol, drying, transferring to a UV OZONE cleaner (Power sonic 405, Hwashin Tech), and then cleaning the substrate for 5 minutes using UV. The substrate was transferred to a vacuum evaporator.

상기와 같이 준비된 ITO 투명 전극 위에, DS-205 (㈜두산전자, 80 nm)/NPB (15 nm)/ADN + 5 % DS-405 (㈜두산전자, 30nm)/화합물 1, 8, 17, 29, 89, 96, 105, 117, 177, 184, 193, 195, 209, 213, 214, 216, 225, 226, 227, 228 각각의 화합물 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제작하였다.On the ITO transparent electrode prepared as above, DS-205 (Doosan Electronics Co., Ltd., 80 nm)/NPB (15 nm)/ADN + 5% DS-405 (Doosan Electronics Co., Ltd., 30nm)/Compound 1, 8, 17, 29 , 89, 96, 105, 117, 177, 184, 193, 195, 209, 213, 214, 216, 225, 226, 227, 228 each compound (30 nm)/LiF (1 nm)/Al (200 nm) ) to produce an organic electroluminescent device.

[[ 비교예Comparative example 1] 청색 유기 1] Blue Organic 전계electric field 발광 소자의 제작 Fabrication of light emitting devices

전자 수송층 물질로서 화합물 1 대신 Alq3을 사용하는 것을 제외하고는, 상기 실시예 1과 동일하게 수행하여 청색 유기 전계 발광 소자를 제작하였다.A blue organic electroluminescent device was manufactured in the same manner as Example 1, except that Alq3 was used instead of Compound 1 as the electron transport layer material.

[[ 비교예Comparative example 2] 청색 유기 2] Blue Organic 전계electric field 발광 소자의 제작 Fabrication of light emitting devices

전자 수송층 물질로서 화합물 1을 사용하지 않은 것을 제외하고는, 상기 실시예 1과 동일하게 수행하여 청색 유기 전계 발광 소자를 제작하였다.A blue organic electroluminescent device was manufactured in the same manner as Example 1, except that Compound 1 was not used as the electron transport layer material.

상기 실시예 1 내지 20 및 비교예 1, 2에서 사용된 NPB, AND 및 Alq3의 구조는 하기와 같다.The structures of NPB, AND, and Alq3 used in Examples 1 to 20 and Comparative Examples 1 and 2 are as follows.

Figure 112017002963439-pat00084
Figure 112017002963439-pat00084

[[ 평가예Evaluation example 1] One]

실시예 1 내지 20 및 비교예 1, 2 에서 제작한 각각의 청색 유기 전계 발광 소자에 대하여 전류밀도 (10) mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.For each blue organic electroluminescent device manufactured in Examples 1 to 20 and Comparative Examples 1 and 2, the driving voltage, current efficiency, and luminescence peak at a current density (10) mA/cm2 were measured, and the results are shown in the table below. It is shown in 1.

샘플Sample 전자 수송층electron transport layer 구동 전압
(V)
driving voltage
(V)
EL 피크
(nm)
EL peak
(nm)
전류효율
(cd/A)
Current efficiency
(cd/A)
실시예 1Example 1 1One 4.54.5 458458 7.07.0 실시예 2Example 2 88 4.64.6 459459 7.17.1 실시예 3Example 3 1717 4.14.1 458458 7.17.1 실시예 4Example 4 2929 4.04.0 455455 6.86.8 실시예 5Example 5 8989 4.34.3 456456 6.76.7 실시예 6Example 6 9696 4.44.4 457457 6.76.7 실시예 7Example 7 105105 3.93.9 456456 6.96.9 실시예 8Example 8 117117 3.83.8 452452 7.17.1 실시예 9Example 9 177177 4.04.0 448448 7.37.3 실시예 10Example 10 184184 4.14.1 460460 7.37.3 실시예 11Example 11 193193 3.63.6 468468 6.86.8 실시예 12Example 12 195195 3.53.5 465465 6.96.9 실시예 13Example 13 209209 3.93.9 457457 6.86.8 실시예 14Example 14 213213 4.14.1 456456 6.46.4 실시예 15Example 15 214214 4.14.1 455455 6.56.5 실시예 16Example 16 216216 4.24.2 459459 6.56.5 실시예 17Example 17 225225 4.14.1 461461 6.96.9 실시예 18Example 18 226226 3.93.9 464464 7.17.1 실시예 19Example 19 227227 3.63.6 467467 7.17.1 실시예 20Example 20 228228 3.93.9 467467 6.76.7 비교예 1Comparative Example 1 Alq3 Alq 3 4.74.7 458458 5.65.6 비교예 2Comparative Example 2 -- 4.84.8 460460 6.26.2

상기 표 1에 나타낸 바와 같이, 본 발명의 화합물을 전자 수송층에 사용한 청색 유기 전계 발광 소자(실시예 1 내지 20)는 종래의 Alq3를 전자 수송층에 사용한 청색 유기 전계 발광 소자(비교예 1) 및 전자 수송층이 없는 청색 유기 전계 발광 소자(비교예 2)에 비해 구동전압, 발광피크 및 전류효율 면에서 우수한 성능을 나타내는 것을 알 수 있었다.As shown in Table 1, the blue organic electroluminescent device using the compound of the present invention in the electron transport layer (Examples 1 to 20) is the same as the blue organic electroluminescent device using the conventional Alq 3 in the electron transport layer (Comparative Example 1) and It was found that it exhibited superior performance in terms of driving voltage, emission peak, and current efficiency compared to the blue organic electroluminescent device without an electron transport layer (Comparative Example 2).

Claims (10)

하기 화학식 1로 표시되는 화합물:
[화학식 1]

상기 화학식 1에서,
X1 및 X2는 모두 N이고;
m 및 n은 0이며;
R1 및 R2는 수소이며;
L1 및 L2는 각각 독립적으로 단일결합 및 C6~C12의 아릴렌기로 이루어진 군에서 선택되나, L1 및 L2 중 적어도 하나는 단일결합이고,
L3는 단일결합 및 C6~C12의 아릴렌기로 이루어진 군에서 선택되며;
R3 및 R4 중 어느 하나는 C6~C60의 아릴기이고, 나머지 하나는 하기 화학식 A-3, A-4, A-6 내지 A-11, B-2 및 B-4 내지 B-6으로 이루어진 군에서 선택된 치환기이며;


상기 화학식 A-3, A-4, A-6 내지 A-11, B-2 및 B-4 내지 B-6에서,
*은 결합이 이루어지는 부분을 의미하고;
p 및 l은 각각 독립적으로 0 내지 4의 정수이며;
q 및 t는 각각 독립적으로 0 내지 3의 정수이며;
R6은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 상기 R6이 복수 개인 경우 이들은 서로 동일하거나 상이하며;
R7 및 R8은 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴아민기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택되거나, 인접하는 기와 결합하여 축합 고리를 형성할 수 있고, 상기 R7 및 R8 각각이 복수 개인 경우 이들은 서로 동일하거나 상이하며;
상기 L1 내지 L3의 아릴렌기와, R6 내지 R8의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며,
상기 R3 및 R4 중 어느 하나인 C6~C60의 아릴기는 각각 독립적으로 C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기 및 C6~C60의 아릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있다.
Compound represented by Formula 1:
[Formula 1]

In Formula 1,
X 1 and X 2 are both N;
m and n are 0;
R 1 and R 2 are hydrogen;
L 1 and L 2 are each independently selected from the group consisting of a single bond and an arylene group of C 6 to C 12 , but at least one of L 1 and L 2 is a single bond,
L 3 is selected from the group consisting of a single bond and a C 6 to C 12 arylene group;
One of R 3 and R 4 is an aryl group of C 6 to C 60 , and the other is an aryl group of the following formulas A-3, A-4, A-6 to A-11, B-2 and B-4 to B- It is a substituent selected from the group consisting of 6;


In the formulas A-3, A-4, A-6 to A-11, B-2 and B-4 to B-6,
* refers to the part where the combination takes place;
p and l are each independently an integer from 0 to 4;
q and t are each independently integers from 0 to 3;
R 6 is hydrogen, deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 3 to C 40 cycloalkyl group, Heterocycloalkyl group with 3 to 40 nuclear atoms, aryl group with C 6 to C 60 , heteroaryl group with 5 to 60 nuclear atoms, alkyloxy group with C 1 to C 40 , aryloxy group with C 6 to C 60 , C 3 ~ C 40 alkylsilyl group, C 6 ~ C 60 arylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 arylphosphine group , is selected from the group consisting of a C 6 ~ C 60 mono or diarylphosphinyl group and a C 6 ~ C 60 arylamine group, and when there is a plurality of R 6 , they are the same or different from each other;
R 7 and R 8 are each independently selected from deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 to C 40 alkenyl group, C 2 to C 40 alkynyl group, C 6 to C 60 Aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 to C 60 aryloxy group, C 1 to C 40 alkyloxy group, C 3 to C 40 cycloalkyl group, 3 to 40 nuclear atoms Heterocycloalkyl group, C 6 ~ C 60 arylamine group, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 may be selected from the group consisting of an arylphosphine group, a C 6 ~ C 60 mono or diarylphosphinyl group, and a C 6 ~ C 60 arylsilyl group, or may be combined with an adjacent group to form a condensed ring, and R 7 and R 8 when each is plural, they are the same or different from each other;
The arylene group of L 1 to L 3 , the alkyl group of R 6 to R 8 , an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group, a heterocycloalkyl group, an arylamine group. , alkyl silyl group, alkyl boron group, aryl boron group, aryl phosphine group, mono or diaryl phosphinyl group and aryl silyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 to C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group with 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 arylamine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group with 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkyl boron group, C 6 ~ C 60 aryl boron group, C 6 ~ C 60 arylphosphine group, C 6 ~ C 60 mono or diarylphosphinyl group, and C 6 ~ C 60 arylsilyl group. is substituted or unsubstituted with one or more substituents selected from the group consisting of, and when substituted with a plurality of substituents, they may be the same or different from each other,
The aryl group of any one of R 3 and R 4 of C 6 to C 60 is each independently selected from an alkyl group of C 1 to C 40 , an alkenyl group of C 2 to C 40 , an alkynyl group of C 2 to C 40, and a C 6 to C 40 alkyl group. C 60 It is substituted or unsubstituted with one or more substituents selected from the group consisting of aryl groups, and when substituted with a plurality of substituents, these may be the same or different from each other.
삭제delete 삭제delete 삭제delete 제1항에 있어서,
상기 L1 내지 L3는 각각 독립적으로 단일결합, 페닐렌기, 비페닐렌기 및 나프탈레닐기로 이루어진 군에서 선택되는 화합물.
According to paragraph 1,
A compound wherein L 1 to L 3 are each independently selected from the group consisting of a single bond, a phenylene group, a biphenylene group, and a naphthalenyl group.
삭제delete 삭제delete 제1항에 있어서,
상기 화학식 1로 표시되는 화합물은 아래의 화합물로 이루어진 군에서 선택되는 것을 특징으로 하는 화합물:
Figure 112024008535539-pat00091

Figure 112024008535539-pat00092


Figure 112024008535539-pat00094

Figure 112024008535539-pat00095

Figure 112024008535539-pat00096

Figure 112024008535539-pat00097




Figure 112024008535539-pat00101
According to paragraph 1,
The compound represented by Formula 1 is characterized in that it is selected from the group consisting of the following compounds:
Figure 112024008535539-pat00091

Figure 112024008535539-pat00092


Figure 112024008535539-pat00094

Figure 112024008535539-pat00095

Figure 112024008535539-pat00096

Figure 112024008535539-pat00097




Figure 112024008535539-pat00101
(i) 양극, (ii) 음극, 및 (iii) 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서,
상기 1층 이상의 유기물층 중에서 적어도 하나는 제1항의 화학식 1로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자.
An organic electroluminescent device comprising (i) an anode, (ii) a cathode, and (iii) one or more organic material layers interposed between the anode and the cathode,
An organic electroluminescent device, wherein at least one of the one or more organic layers includes the compound represented by the formula (1) of claim 1.
제9항에 있어서,
상기 화합물을 포함하는 유기물층은 정공 주입층, 정공 수송층, 전자 수송층, 전자 수송 보조층, 전자 주입층, 수명 개선층, 발광층 및 발광 보조층으로 이루어진 군에서 선택되는 유기 전계 발광 소자.
According to clause 9,
The organic material layer containing the compound is an organic electroluminescent device selected from the group consisting of a hole injection layer, a hole transport layer, an electron transport layer, an electron transport auxiliary layer, an electron injection layer, a lifespan improvement layer, a light emitting layer, and a light emitting auxiliary layer.
KR1020150171591A 2015-12-03 2015-12-03 Organic compounds and organic electro luminescence device comprising the same KR102656918B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
KR1020150171591A KR102656918B1 (en) 2015-12-03 2015-12-03 Organic compounds and organic electro luminescence device comprising the same
PCT/KR2016/013827 WO2017095100A1 (en) 2015-12-03 2016-11-29 Organic compound and organic electroluminescent element comprising same

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020150171591A KR102656918B1 (en) 2015-12-03 2015-12-03 Organic compounds and organic electro luminescence device comprising the same

Publications (2)

Publication Number Publication Date
KR20170065317A KR20170065317A (en) 2017-06-13
KR102656918B1 true KR102656918B1 (en) 2024-04-16

Family

ID=58797272

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020150171591A KR102656918B1 (en) 2015-12-03 2015-12-03 Organic compounds and organic electro luminescence device comprising the same

Country Status (2)

Country Link
KR (1) KR102656918B1 (en)
WO (1) WO2017095100A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6928534B2 (en) * 2017-10-18 2021-09-01 株式会社日本触媒 Materials for organic electroluminescent devices and organic electroluminescent devices
JP7134557B2 (en) * 2017-10-18 2022-09-12 株式会社日本触媒 Nitrogen-containing condensed polycyclic heteroaromatic ring compounds
JP7025885B2 (en) * 2017-10-18 2022-02-25 株式会社日本触媒 Nitrogen-containing condensed polycyclic complex aromatic ring compound
CA3085147A1 (en) 2017-12-22 2019-06-27 Petra Pharma Corporation Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
WO2019151733A1 (en) * 2018-02-02 2019-08-08 주식회사 엘지화학 Organic light emitting diode
EP3527557A1 (en) * 2018-02-16 2019-08-21 Novaled GmbH N-heteroarylene compounds
CN108409730B (en) * 2018-02-26 2023-04-07 华南理工大学 Organic small molecule electron transport material and preparation thereof, n-doped electron transport layer and application
CN111683929A (en) * 2018-03-02 2020-09-18 Sk材料有限公司 Compound, organic light emitting device and display device
JP7039412B2 (en) * 2018-07-25 2022-03-22 保土谷化学工業株式会社 Azaindeno [1, 2, c] A compound having a phenanthrene ring structure and an organic electroluminescence device using the compound.
KR20200077951A (en) * 2018-12-21 2020-07-01 두산솔루스 주식회사 Organic compounds and organic electro luminescence device comprising the same
JP7495231B2 (en) * 2019-02-08 2024-06-04 住友化学株式会社 Compound and light-emitting device using same
JP7285663B2 (en) * 2019-03-15 2023-06-02 東ソー株式会社 Triazine compound having a 2'-arylbiphenylyl group
WO2020222097A1 (en) * 2019-04-30 2020-11-05 株式会社半導体エネルギー研究所 Light-emitting device, light-emitting apparatus, electronic equipment, and lighting apparatus
TW202112784A (en) 2019-06-17 2021-04-01 美商佩特拉製藥公司 Chromenopyrimidine derivatives as phosphatidylinositol phosphate kinase inhibitors
JP7361564B2 (en) * 2019-10-23 2023-10-16 東ソー株式会社 Triazine compounds containing Group 14 elements
KR102301533B1 (en) * 2019-10-25 2021-09-16 엘티소재주식회사 Heterocyclic compound and organic light emitting device comprising same
KR102509034B1 (en) * 2020-02-13 2023-03-10 삼성디스플레이 주식회사 Organic light emitting device and apparatus including the same
CN114497394A (en) * 2020-10-23 2022-05-13 江苏三月科技股份有限公司 Organic electroluminescent device
CN113004295B (en) * 2021-03-11 2022-07-19 吉林奥来德光电材料股份有限公司 Triazine electron transport material, preparation method and application thereof
CN113321649B (en) * 2021-04-23 2023-05-30 烟台显华化工科技有限公司 Compound, electron transport material and organic electroluminescent device

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010090034A (en) * 2008-10-03 2010-04-22 Tosoh Corp 1,3,5-triazine compound, manufacturing method of the same, and organoelectroluminescent element comprising the same as constituent
JP2015205235A (en) * 2014-04-18 2015-11-19 東ソー株式会社 Method of removing palladium from triazine compound using activated charcoal

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9252368B2 (en) * 2011-11-11 2016-02-02 Tosoh Corporation Cyclic azine compound having nitrogen-containing condensed aromatic group, method for producing same, and organic electroluminescent device comprising same as constituent component
KR102179763B1 (en) * 2014-04-23 2020-11-17 덕산네오룩스 주식회사 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof
KR102432080B1 (en) * 2014-12-08 2022-08-16 엘지디스플레이 주식회사 Organic Light Emitting Display Device
KR101867661B1 (en) * 2015-01-21 2018-06-15 주식회사 엘지화학 Hetero-cyclic compound and organic light emitting device comprising the same

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010090034A (en) * 2008-10-03 2010-04-22 Tosoh Corp 1,3,5-triazine compound, manufacturing method of the same, and organoelectroluminescent element comprising the same as constituent
JP2015205235A (en) * 2014-04-18 2015-11-19 東ソー株式会社 Method of removing palladium from triazine compound using activated charcoal

Also Published As

Publication number Publication date
WO2017095100A1 (en) 2017-06-08
KR20170065317A (en) 2017-06-13

Similar Documents

Publication Publication Date Title
KR102656918B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102559792B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102703998B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102617944B1 (en) Organic compound and organic electroluminescent device using the same
KR102508486B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102665870B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102610868B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101571592B1 (en) Organic compound and organic electroluminescent device comprising the same
KR102617612B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20180128180A (en) Organic compounds and organic electro luminescence device comprising the same
KR101599597B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102599592B1 (en) Organic compound and organic electroluminescent device using the same
KR102559589B1 (en) Organic compound and organic electroluminescent device including the same
KR20160076881A (en) Organic light-emitting compound and organic electroluminescent device comprising the same
KR102587381B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102692902B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR20150086069A (en) Organic compounds and organic electro luminescence device comprising the same
KR102685447B1 (en) Organic light-emitting compound and organic electroluminescent device using the same
KR102441870B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR101577099B1 (en) Organic compound and organic electroluminescent device comprising the same
KR101612160B1 (en) Organic compound and organic electroluminescent device comprising the same
KR102692891B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102587380B1 (en) Organic compounds and organic electro luminescence device comprising the same
KR102642888B1 (en) Organic compound and organic electroluminescent device using the same
KR20160078102A (en) Organic compound and organic electroluminescent device comprising the same

Legal Events

Date Code Title Description
AMND Amendment
A201 Request for examination
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
AMND Amendment
E902 Notification of reason for refusal
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant